[ad_1]
SHANGHAI: A vaccine scandal in China, which has shaken the country and prompted quick reactions from Beijing's leaders, shakes the national drug market while threatening to undermine China's ambitions to play a global role most important.
Shares of Chinese vaccine and biotechnology manufacturers fell on Monday after Prime Minister Li Keqiang criticized Changsheng Biotechnology Co for crossing a red line and calling for swift action.
The case broke a week It was found that Changsheng had violated the standards for rabies vaccine.
Although there have been no reports that people have been injured or have contracted rabies, the regulatory body has already ordered Changsheng to Stop production. all his vaccines
The case has become viral in China, where the sensitivity to the safety of food and drugs is extremely high after a series of scandals throughout the year. last decade. Shares of Changsheng, which have lost 40% since mid-July, were suspended Monday.
The scandal sparked anger on social media and dealt a blow to the Chinese regulator, who fought to cleanse the second-largest drug
It's also a setback for the country as it seeks to play a greater role globally in the production and export of vaccines and other drugs.
In a statement posted on the government's website Sunday night, Prime Minister Li called for an immediate investigation and called for severe punishment for the companies and people involved. "We will resolutely repress illegal and criminal acts that endanger people's lives, punish violators in accordance with the law, and severely and severely criticize the breach of duty in the surveillance," he added. He said in a statement that his investigation had revealed that Changsheng was producing production records and product inspection records, and that it was arbitrarily changing the parameters and equipment of the process, in " serious violations "of the law. 19659002] PUBLIC HEALTH CRISIS
Changsheng stated in a regulatory file that the suspension of its production of rabies vaccines would have a significant impact on its finances and that some regional disease control agencies had suspended some of its other vaccines.
Monday in the China Daily warned that the case could become a public health crisis if it is not treated "in a reasonable and transparent manner". "
" The government must act as quickly as possible to let the public know that it is resolved to tackle the problem and that it will punish all the ruthless criminals ", he added.
The Xinhua News Agency has issued an editorial calling for harsh penalties for all violations, large or small, in the vaccine industry and for regulators to fill the gaps and strengthen the industry monitoring
. "
" Cases like Changsheng Biotechnology, where laws and regulations are ignored and internal controls exist only by name, bring a painful price, "says he made a public apology and recalled all their rabies vaccines available on the market
(report by John Ruwitch and Adam Jourdan, edited by Himani Sarkar)
[ad_2]
Source link
